Amorphical brings Scientific Breakthrough - Treating and Curing Chronic Inflammatory and Oncological Diseases

Contributed by: PR Newswire

Images

PR Newswire associated0

Tags

Amorphical

More Like This

The structural model of amorphous carbon (left), estimated by TXS-RMC using SmartLab (right) (Graphic: Business Wire)

Rigaku Develops Technology for 3D Visualization of the Atomic-scale Structure of Amorphous Carbon

Inside information made public: Nanoform Announces Important Milestone with Promising Clinical Results for Patient-Centric Nanotechnology-Enhanced Enzalutamide

Nanoform Commenced Relative Bioavailability Study of Nanotechnology-Enhanced Enzalutamide

Dr. Aron Blaesi, inventor of expandable, gastroretentive fibrous dosage forms presenting dosage forms before and after expansion due to water absorption. (Photo: Business Wire)

Enzian Pharmaceutics Develops a Novel Dosage Form for Enhanced Efficacy and Reduced Side Effects of Cancer Therapies

Nanoform's biologics technology showcased by large pharma at drug delivery conference; Nanoenzalutamide and nanoapalutamide partnering discussions progress as planned

PR Newswire associated0

Agepha Pharma and Caristo Diagnostics Team Up to Fight Coronary Inflammation

Inside information made public: Nanoform Wins R&D Grant of EUR 4.3M for Research Into Nanoparticle Enabled Formulations for Next Generation Medicines

Innophos Dicalcium and Tricalcium Phosphates now available in EC Grade (Graphic: Business Wire)

Innophos Upgrades Production Facility for EC Grade Calcium Phosphates